Hemophagocytic Lymphohistiocytosis Activation Syndrome with Multi-Organ Co-Infections: A Therapeutic Dilemma
DOI:
https://doi.org/10.17161/kjm.vol16.20957Keywords:
hemophagocytic lymphohistiocytosis, Tuberculosis, hepatitis A, COVIDMetrics
Metrics Loading ...
Downloads
Published
2023-10-30
Issue
Section
Case Reports
License
Copyright (c) 2023 Shivangi Gohil, M.D., Hannah Berrett, M.D., Ph.D., Rebecca Kurian, M.D., Johnathon Phillips, M.D., Mala Goyal, M.D., Francis Dailey, M.D.
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0).
How to Cite
Shivangi Gohil, Berrett, H., Kurian, R., Phillips, J., Goyal, M., & Dailey, F. (2023). Hemophagocytic Lymphohistiocytosis Activation Syndrome with Multi-Organ Co-Infections: A Therapeutic Dilemma. Kansas Journal of Medicine, 16(3), 268-270. https://doi.org/10.17161/kjm.vol16.20957